Signant Health
- 1
- 2
Signant Health and SPRIM PRO Align to Advance eClinical Solutions for Specialized Clinical Research
30 October 2024 -- Pennsylvania, US -- Signant Health, the leader in evidence generation for modern clinical trials, today announced a strategic alignment with SPRIM PRO, a boutique contract research organization (CRO) specializing in biopharmaceutical, nutrition, medical technology, and consumer health research. This collaboration combines Signant's innovative eClinical technology solution with SPRIM PRO's expertise in...
Signant Health Appoints 20-Year Life Sciences Veteran Paul Richmond to executive leadership team as chief commercial officer
15 July 2024 – Pennsylvania, US – Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Paul Richmond as chief commercial officer. A life sciences leader with over 20 years’ experience working with biopharma, biotech and contract research organisations (CROs), Paul’s deep industry knowledge and expansive clinical network...
Signant Health extends eCOA leadership position through operational innovations that reduce timelines by at least one-third
8 May 2024 -- Pennsylvania, US -- Signant Health, the leader in evidence generation for modern clinical trials, announced today that it has substantially reduced implementation timelines for its flagship eCOA solution, TrialMax. By leveraging process and technology enhancements, Signant’s operational teams can reduce the time it takes to go live with electronic patient-reported outcomes...
Signant Health Unveils Next-Level Advancements in Efficient, Compliant IP Management with Updates to its Clinical Supply Solutions
6 March 2024 -- Pennsylvania, US -- Signant Health, the leader in evidence generation for modern clinical trials, announced today the release of key enhancements to its clinical supply management solutions, Signant SmartSignals GxP Inventory and Signant SmartSignals RTSM. Clinical research sponsors use these solutions to streamline investigational product (IP) and enterprise-wide supply chain management....
Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical Development for Emerging Biopharmaceutical Organisations
3 October 2023 -- Philadelphia, US -- Signant Health, the leader in evidence generation for modern clinical trials, announced today the launch of Signant Biotech – an integrated clinical research approach leveraging software and services tailored to the unique needs of small- to mid-sized biopharmaceutical organisations. Signant Biotech is anchored by a unified technology platform...
Signant Health Announces Readiness to Facilitate Customers’ Compliance with China’s Personal Information Protection Law (PIPL) for Clinical Trial Data Collection
26 September 2023 -- Pennsylvania, US -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it has finalised technical and operational investments required to support customers’ compliance with China’s Personal Information Protection Law (PIPL) for clinical trial data collection. The PIPL includes provisions that govern how clinical research sponsors process...
Signant‪s Novel Electronic PROMIS CAT Assessment Enhances Patient-Centric Drug Development
PHILADELPHIA, PA - February 8, 2023 - Signant Health, the leader in evidence generation for modern clinical trials, announced today the ability to deliver computerized adaptive tests (CATs) in clinical trials utilizing the Patient-Reported Outcome Measure Information System (PROMIS), designed to reduce patient completion burden while maintaining measurement precision of patient-reported outcomes.
Signant Health Debuts Standardized Electronic Seizure Diary Developed in Collaboration with The Epilepsy Study Consortium
PHILADELPHIA, PA - January 17, 2023 - Signant Health, the leader in evidence generation for modern clinical trials, introduced today a novel electronic diary (eDiary) data capture solution designed to simplify the experience for patients and research sites participating in epilepsy trials while ensuring robust outcome assessment data to support trial endpoints. Developed in collaboration...
Signant Partners with Loftware for Adaptive Investigational Product Labeling
Collaboration reinforces Signant's end-to-end clinical supplies management solutions and supports the complex manufacturing and distribution models inherent in modern clinical research
Signant Strengthens Digitally Optimized Trial Strategy with Delivery of Study Supplies Direct to Patients‚Ä™ Homes
Signant Health, the leader in evidence generation for modern clinical trials, announced today enhancements to its Randomization and Trial Supply Management (RTSM) platform to enable direct-to-patient clinical supply distribution.
- 1
- 2
4000 Chemical Road Suite 300 Plymouth Meeting, PA 19462
+1 267 498 2300
